Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shantanu Banerji

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Current Oncology (Toronto, Ont.)|July 25, 2022
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung CancerDiana N Ionescu, Tracy L Stockley, Shantanu Banerji, et al.
Therapeutic Advances in Medical Oncology|January 8, 2025
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancerBarbara Melosky, Rosalyn A Juergens, Shantanu Banerji, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World ExperienceMartin Rupp, Fiorella Fanton-Aita, Stephanie Snow, et al.
JAMA Network Open|August 9, 2020
Association of Mindfulness-Based Interventions With Anxiety Severity in Adults With Cancer: A Systematic Review and Meta-analysisSapna Oberoi, Jiayu Yang, Roberta L Woodgate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2024
Mental Disorders Among Adolescents and Young Adults With Cancer: A Canadian Population-Based and Sibling Cohort StudySapna Oberoi, Allan Garland, Adam P Yan, et al.
Genes & Development|July 19, 2011
Nuclear factor I/B is an oncogene in small cell lung cancerAlison L Dooley, Monte M Winslow, Derek Y Chiang, et al.
Current Oncology (Toronto, Ont.)|January 20, 2021
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsD Gwyn Bebb, Shantanu Banerji, Normand Blais, et al.
Cancer Medicine|January 19, 2026
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyTalya Wittmann Dayagi, Hagit Peretz Soroka, Alannah Smrke, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|July 25, 2022
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung CancerDiana N Ionescu, Tracy L Stockley, Shantanu Banerji, et al.
Therapeutic Advances in Medical Oncology|January 8, 2025
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancerBarbara Melosky, Rosalyn A Juergens, Shantanu Banerji, et al.
Current Oncology (Toronto, Ont.)|July 28, 2023
Lorlatinib Effectiveness and Quality-of-Life in Patients with ALK-Positive NSCLC Who Had Failed Second-Generation ALK Inhibitors: Canadian Real-World ExperienceMartin Rupp, Fiorella Fanton-Aita, Stephanie Snow, et al.
JAMA Network Open|August 9, 2020
Association of Mindfulness-Based Interventions With Anxiety Severity in Adults With Cancer: A Systematic Review and Meta-analysisSapna Oberoi, Jiayu Yang, Roberta L Woodgate, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2024
Mental Disorders Among Adolescents and Young Adults With Cancer: A Canadian Population-Based and Sibling Cohort StudySapna Oberoi, Allan Garland, Adam P Yan, et al.
Genes & Development|July 19, 2011
Nuclear factor I/B is an oncogene in small cell lung cancerAlison L Dooley, Monte M Winslow, Derek Y Chiang, et al.
Current Oncology (Toronto, Ont.)|January 20, 2021
Canadian Consensus for Biomarker Testing and Treatment of TRK Fusion Cancer in AdultsD Gwyn Bebb, Shantanu Banerji, Normand Blais, et al.
Cancer Medicine|January 19, 2026
A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) StudyTalya Wittmann Dayagi, Hagit Peretz Soroka, Alannah Smrke, et al.
Cancer Medicine|September 19, 2023
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) studyHagit Peretz Soroka, Tushar Vora, Jonathan Noujaim, et al.
Neuro-Oncology|January 22, 2015
Phase II study of PX-866 in recurrent glioblastomaMarshall W Pitz, Elizabeth A Eisenhauer, Mary V MacNeil, et al.
Pageof 5